Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e53ddadc8822457d5979471ddd1d8ab8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 |
filingDate |
2021-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a2cc426bf83bca534ed9c2fcd87200 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ef5670c0f1e156ab4a75f3958ea1a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4145b17426d2ca5cc92e049283b3fe |
publicationDate |
2021-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021182876-A1 |
titleOfInvention |
Pharmaceutical composition for prevention or treatment of nonalcoholic steatohepatitis |
abstract |
The present invention relates to a pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease. The pharmaceutical composition according to the present invention exhibits excellent effects of improving lipid metabolism, reducing fat accumulation in liver tissues and inhibiting histological damage caused by inflammation and fibrosis of liver tissues, and thus can be effectively used as a use of preventing or treating nonalcoholic fatty liver disease. |
priorityDate |
2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |